Hormones and Sarcopenia

• Published in: Current pharmaceutical design Vol. 23; no. 30; p. 4484
• Main Author: Morley, John E
• Format: Journal Article
• Language: English
• Published: United Arab Emirates 28.11.2017
• Subjects: Hormones - deficiency; Human Growth Hormone - deficiency; Humans; Insulin - deficiency; Insulin Resistance; Muscle Strength - physiology; Prevalence; Sarcopenia - epidemiology; Sarcopenia - physiopathology; Sarcopenia - therapy; Testosterone - blood; Vitamin D - administration & dosage; Vitamin D - blood; Vitamin D Deficiency - complications; Sarcopenia; frailty; Vitamin D; hormones; disability; muscle

Sarcopenia is defined as the loss of muscle mass associated with a loss of muscle function, e.g., walking speed. A number of consensus definitions exist for sarcopenia with cut-off points being ethnically specific. A rapid screen test (SARC-F) is available and does not require different ethnic cut-o...